All posts by medical
Cardiovascular Genetic Testing Market to Witness High Growth in Near Future and Competitive Analysis – PRnews Leader
The latest Report release from Database of Data Bridge Market Research has recently published the research Report TitledCardiovascular Genetic Testing Market. The study provides an overview of current statistics and future predictions of the Global Cardiovascular Genetic Testing Market.The study highlights a detailed assessment of the Market and displays market sizing trends by revenue & volume (if applicable), current growth factors, expert opinions, facts, and industry-validated market development data.
Cardiovascular genetic testing market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 4.01 billion by 2027 growing at a CAGR of 13.40% in the above-mentioned forecast period. An extensive array of employment of genetic experimentation in inherent disorders and oncology will prove advantageous for genetic testing business germination in the coming years.
Get Free Sample PDF (including COVID19 Impact Analysis) of Cardiovascular Genetic Testing Market[emailprotected]https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cardiovascular-genetic-testing-market
Prominent Key Players Covered in the report:
Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, QIAGEN, Pathway Genomics, Pacific Biosciences of California, Inc, Natera, Inc., Myriad Genetics, Inc., ICON plc, Laboratory Corporation of America Luminex Corporation, IntegraGen., HTG Molecular Diagnostics, Inc. , Genomic Health, Inc., Admera Health, deCODE genetics among other domestic and global players.(Customization Available)
The GlobalCardiovascular Genetic Testing Marketresearch report assembles data collected from different regulatory organizations to assess the growth of the segments. In addition, the study also appraises the global Cardiovascular Genetic Testing market on the basis of topography. It reviews the macro- and microeconomic features influencing the growth of the Cardiovascular Genetic Testing Market in each region. Various methodological tools are used to analyze the growth of the worldwide Cardiovascular Genetic Testing market.
Major Regions as Follows:
Global Cardiovascular Genetic Testing Market Research Reportalso provides the latest companies data and industry future trends, allowing you to identify the products and end users driving profits growth and productivity. The Market report lists the most important competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, investigation and discussion of significant industry trends, market volume, market share estimates and profiles of the leading industry Players. Global Cardiovascular Genetic Testing Industry Market Research Report is providing exclusive vital statistics, information, data, trends and competitive landscape details. The Global Cardiovascular Genetic Testing market SWOT is provided for the international markets including progress trends, competitive landscape breakdown, and key in regions development status.
The Cardiovascular Genetic Testing report study has Three major sections which include:
Section 1:Market Introduction
This section deals with the Cardiovascular Genetic Testing market definition or the market along with the target audience of the market. Later in the chapters, the research methodologies and the market tools that were used for the market analysis is mentioned.
Section 2:Cardiovascular Genetic Testing Market DROC
The flow of this section is: Cardiovascular Genetic Testing market growth factors and limitations. In the later chapters, the Cardiovascular Genetic Testing market opportunities and challenges are described. All the points mentioned within the report are updated based on the COVID-19 situation.
Section 3:Conclusion and Observations
The last section of the report includes comments and observations by the research analysts and the market experts for the Cardiovascular Genetic Testing market.
Get Table Of Contents of This Premium Research For Free:https://www.databridgemarketresearch.com/toc/?dbmr=global-cardiovascular-genetic-testing-market
How Does This Market Insights Help?
Key Pointers Covered in the Cardiovascular Genetic Testing Market Industry Trends and Forecast
Why choose us:
Market Dynamics:The Cardiovascular Genetic Testing report also demonstrates the scope of the various commercial possibilities over the coming years and the positive revenue forecasts in the years ahead. It also studies the key markets and mentions the various regions i.e. the geographical spread of the industry.
Strategic Points Covered in Table of Content of Global Cardiovascular Genetic Testing Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Cardiovascular Genetic Testing market
Chapter 2: Exclusive Summary the basic information about the Cardiovascular Genetic Testing Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Cardiovascular Genetic Testing
Chapter 4: Presenting the Cardiovascular Genetic Testing Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying market size by Type, End-User and Region 2010-2019
Chapter 6: Evaluating the leading manufacturers of the Cardiovascular Genetic Testing market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries.
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
Finally, Cardiovascular Genetic Testing Market is a valuable source of guidance for individuals and companies in the decision framework.
Cardiovascular Genetic Testing Marketwill prove as a valuable source of guidance for professional clients like Tier 1, Tier 2, Tier 3 level managers, CEOs, CMOs, as well as the interested individual readers across the world. Vendor Landscape provide acts as key development and focus of above professional with common aim to lead the way of Cardiovascular Genetic Testing Market Worldwide
In conclusion, the Cardiovascular Genetic Testing Market report is a reliable source for accessing the research data that is projected to exponentially accelerate your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis is also incorporated in the report along with speculation attainability investigation and venture return investigation.
Get Enquiry About This Comprehensive Report:https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cardiovascular-genetic-testing-market
Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Customization of the Report:
Data Bridge Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.
Contact:
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
[emailprotected]
Mount Sinai Doctors Elected to National Academy of Medicine for Contributions to Emergency Medicine and Translational Genetics – Newswise
Newswise (New York, NY October 19, 2020) Brendan G. Carr, MD, MA, MS, Chair of Emergency Medicine for the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System, and Judy H. Cho, MD, Dean of Translational Genetics at the Icahn School of Medicine at Mount Sinai and Director of The Charles Bronfman Institute for Personalized Medicine, have been elected to the National Academy of Medicine (NAM). Election to the NAM is considered one of the highest honors in health and medicine, recognizing individuals who have demonstrated outstanding professional achievement and commitment to service. With their election, Mount Sinai has 25 faculty members in the NAM.
The recognitions of Dr. Carr and Dr. Cho are well deserved for their groundbreaking contributions to emergency medicine and translational genetics, says Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai. Dr. Carrs research has focused not only on improving the emergency care system for time-sensitive conditions such as trauma, stroke, cardiac arrest, and sepsis, but also on creating a more distributed and innovative approach to increasing access to acute care. Likewise, Dr. Cho is committed to improving care through personalized medicine and the understanding of each patients unique genes. She has enhanced genetic research, clinical implementation, and data platforms to ensure Mount Sinai remains at the forefront of genetic discoveries and implementation.
Emergency Medicine A leading voice in emergency medicine, Dr. Carr played a central role in coordinating Mount Sinais response to the COVID-19 pandemic. He has dedicated his career as an emergency medicine physician and health policy researcher to seamlessly combining research, policy, and practice to advance acute care delivery. Before joining Mount Sinai in February 2020, Dr. Carr held faculty positions at the Sidney Kimmel Medical College at Thomas Jefferson University and the Perelman School of Medicine at the University of Pennsylvania.
Outside academia, Dr. Carr has worked within the U.S. Department of Health and Human Services during both the current and previous administrations to improve trauma and emergency care services at the national level. His roles have included Senior Advisor and Director of the Emergency Care Coordination Center within the Office of the Assistant Secretary for Preparedness and Response, focusing on integrating the emergency care system into the broader health care delivery system. He previously supported the Indian Health Services initiatives to improve emergency care delivery, and worked with the Department of Veterans Affairs and the Department of Defense to integrate military and civilian health care response during disasters and public health emergencies. Dr. Carr has advised and supported major not-for-profit foundations, the World Health Organization, and the National Academy of Medicine.
He conducts health services research that connects disciplines including epidemiology, health care policy, business, economics, and health care delivery system science. His work has been continuously funded by the National Institutes of Health, the Centers for Disease Control and Prevention, and the Agency for Healthcare Research and Quality. He has published and lectured widely on systems of care for trauma, stroke, cardiac arrest, and sepsis.
Ive spent my career focused on improving access to high-quality emergency care and am extremely humbled to be recognized by my peers with this honor. The recent COVID-19 surge reminded us of the importance of building robust systems that meet the needs of the communities that we serve. Im incredibly grateful for the opportunities Ive been given and the mentors that have helped to guide my career, says Dr. Carr. I am particularly grateful to be honored alongside my Mount Sinai colleague.
Translational Genetics Dr. Cho is an internationally recognized expert on the genetics and genomics of inflammatory bowel disease. As Dean of Translational Genetics, she leads strategic planning and integration of translational genetics research and care across school departments and institutes, with a focus on the rapid application of genetic and genomic discoveries to improve patient care. She also holds the Ward-Coleman Chair in Translational Genetics as well as professorships in Genetics and Genomic Sciences, and Medicine.
In 2013, Dr. Cho joined the Icahn School of Medicine faculty following appointments at the Yale University School of Medicine and the University of Chicago Pritzker School of Medicine. For the past five years, she has been Director of The Charles Bronfman Institute for Personalized Medicine and overseen the BioMe Biobank program, a pioneer in the movement toward diagnosis and classification of disease according to the patients molecular profile.
Science generally, and genetics especially, is a team sport; this recognition reflects many, many close collaborations over the years, says Dr. Cho. It is a privilege to try to advance science to help patients, and genetic discovery provides a particularly powerful means of prioritizing novel therapeutic targets.
Dr. Cho also leads an independent research program that is generously funded by the National Institutes of Health (NIH) and other extramural sources, and chairs the External Advisory Committee of the Wellcome Trust Centers for Human Genetics and Cellular Genetics. She has been Principal Investigator of the Data Coordinating Center for the Inflammatory Bowel Disease Genetics Consortium of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) since 2002 and chaired its Steering Committee for 16 years. Previously, she served on the American Society for Clinical Investigation Council and the NIDDK External Advisory Council, and chaired the Genetics of Health and Disease Study Section at the NIH. In 2014, Dr. Cho received the Crohns and Colitis Foundations Lifetime Achievement Award in Basic Science.
New members are elected to the NAM by current, active members through a selective process that recognizes leaders making major contributions to the advancement of the medical sciences, health care, and public health. Established in 1970 by the National Academy of Sciences, NAM is a national resource that provides independent, objective analysis and advice on health issues.
The elections of Dr. Carr and Dr. Cho bring Mount Sinais total membership in the prestigious group to 25 current and emeritus faculty members: Joseph D. Buxbaum, PhD Neil S. Calman, MD, MMS Dennis S. Charney, MD Kenneth L. Davis, MD Robert J. Desnick, MD, PhD Angela Diaz, MD, MPH Valentin Fuster, MD, PhD Bruce Gelb, MD Alison M. Goate, DPhil Kurt Hirschhorn, MD Yasmin L. Hurd, PhD Philip J. Landrigan, MD, MSc Helen S. Mayberg, MD Diane E. Meier, MD Eric J. Nestler, MD, PhD Maria Iandolo New, MD Peter Palese, PhD Ramon E. Parsons, MD, PhD Lynne D. Richardson, MD Hugh A. Sampson, MD Albert Siu, MD, MSPH Barbara G. Vickrey, MD, MPH Rachel Yehuda, PhD.
About the Mount Sinai Health System
The Mount Sinai Health System is New York Citys largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality carefrom prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's Honor Roll of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in the country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty by U.S. News & World Report.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
Go here to read the rest:
Mount Sinai Doctors Elected to National Academy of Medicine for Contributions to Emergency Medicine and Translational Genetics - Newswise
Air Pollution Causes People to Choose Food Delivery Services, Resulting in Plastic Pollution – Science Times
Researchers from the National University of Singapore discovered a link between air pollution and plastic pollution: food delivery services. In a recent study, office employees tend to call food delivery services when the air outside is unfavorable which results in increased plastic waste from single-use food packaging.
The paper was published recently in the Nature journal Human Behavior. Professor Alberto Salvo said that plastic pollution is a global issue that's only gotten worse in the past few years. There has also been more research on the impact of plastic pollution on global environments but there is a lack of research focused on what influences human behavior to contribute to plastic waste.
With the decline of air quality in urban areas, busy work routines, and the current pandemic, the demand for food delivery services have spiked as well. Their evidence, explained Professor Salvo, includes a collection of single-use plastics ranging from food containers to carrier bags.
The team focused on the online food delivery platform, which has the most registered users in the whole world with nearly 350 million users, from China. They surveyed officed workers from three cities, measured particulate matterpollution in the cities, and quantified the tendency of employees ordering food via delivery services.
Results showed that the increase of particulate matter in air pollution had a direct impact on the number of food deliveries to offices. The team estimated that nearly 65 million single-use meal containers are used every day all over China. Office workers contribute to more than 50% of the plastic waste from food deliveries.
In the heavily polluted cities of Beijing, Shenyang, and Shijiazhuang, 251 office workers were surveyed for their lunch choices between for the first six months in 2018. The researchers also analyzed data from 2016 containing more than three million food delivery orders from more than 350,000 users.
The U.S. National Ambient Air Quality Standardis 35 g/m but the three cities were measured to have significantly higher levels of fine particulate matter (PM2.5) concentrations. When PM2.5 levels were increased by 100 g/m, the number of food deliveries increased by 7.2%. At the same time, office worker food deliveries increased by six times.
(Photo: Photo by Tomohiro Ohsumi/Getty Images)
Read Also: Researchers Claim Higher Levels of Air Pollution Increases Electricity Consumption
Professor Junhong Chu said that ordering food via delivery services was the only way that office workers could avoid smog or haze outside during their lunch break. Meanwhile, other consumers avoid outdoor pollution by staying at home where they can cook their meals.
"This explains why the impact of air pollution on food delivery is smaller in the firm's order book study than what we observed among workers, particularly those without access to a canteen in their office building," said Chu. On days of greater air pollution in Beijing, 2.5 million more meals would be delivered, meaning a total of five million food containers plus plastic bags.
Professor Haoming Lui shared that although they focused on Chinese cities, the results have implications for other heavily polluted cities such as in India, Vietnam, and Indonesia. Waste management policies are another major factor in the increase in plastic pollution. They hope that their study can help accelerate the movement of food delivery services switching to eco-friendly packagingand vehicles.
Read Also: Tire Pollution May Be a Significant Plastic Pollutant in Oceans, Researchers Reveal
Check out more news and information on Pollutionon Science Times.
See more here:
Air Pollution Causes People to Choose Food Delivery Services, Resulting in Plastic Pollution - Science Times
Hope And The Patient With Cancer – Curetoday.com
As an individual diagnosed more than 5 years ago with multiple myeloma, I have been struck by the reliance on the part of some cancer patients who place significant emphasis on clinical trials and research, and the desire to battle and fight the disease in order to seek cure and avoid untimely death. This emphasis also applies to healthcare providers and researchers, many of whom are the very originators of this focus. Offering hope supports that singular human need to achieve another state of being. As a need, hope is more than an emotional state with something that could be different in our lives.
Hope is a multifaceted human need that drives one to achieve or craft ones life in a certain direction. More than a guide or roadmap for ourselves, our families, our friends and beyond, hope can influence the essence of very fundamental human behavior from birth to death.
There are many ways of examining the concept of hope as it applies to the cancer patient. At its very core, hope and the patient may be seen through the lens of the quality of life or lifestyle, a religious orientation and faith, and the belief in the human soul.
Hope can produce a quality of life which may be considered a lifestyle. That is, our daily behavior from birth onwards is built around a series of ideas, principles, concepts and others thoughts that from a belief system and ultimately organized as a lifestyle. While the concept of lifestyle is a complicated phenomenon, the idea of grouping the many forms of individual human behavior into a set of mostly observable behaviors can have, at its core, the idea of hope. Hope may well be the driving force as we traverse our way through life. And part of this is the idea that hope is an amazing gift from God which underlies the very essence of a positive quality of life or standard by which we live from birth to death.
In many organized religions, hope is part of the foundation of religious faith which is built around the omnipresent force commonly referred as the concept of God. And, as some religions have espoused, the human soul is the persons window to God, which guides our thoughts and beliefs about our future, and ultimately to our understanding about the hereafter. Hope also helps to form three other aspects of human behavior.
These three beliefs are the belief in the human soul, belief in our own future, and finally, a belief in the hereafter. Aside from biological growth and development, the human being also learns, accepts, and inculcates into our being the beliefs in the human soul, our own future, and the hereafter forming our human core. Hope, then, becomes a primary vehicle for understanding human existence.
So, how do we make sense out of this? My own interest in this topic grew out of my volunteer work as a moderator for a digital support group for people with Blood Cancers.
This group is nationally supported by ANCAN, a cancer information organization. In my moderating work I was struck by the almost exclusive interest on the part of participants in medications they were taking, clinical trials they were participating in, details about their chemotherapy designs, and related topics.
Initially, I was shocked to listen to the conversation. As a psychologist, I had much more anticipated that discussion questions about, What are you feeling? How are you coping? What is your family doing to help you? Are you ever angry about getting cancer? If so, how do you express yourself? And to my professional amazement, these discussion points never came up and when asked if they were interested in talking about this, there was only some quiet grumbling.
The good news is that silence almost always works, so after a moment or two, one brave soul said, you know, I always wanted to know what it will feel like when the end for me is near?Understandably, this generated a good deal of healthy discussion. So, from a hope perspective perhaps what I call Medication Talk is really Help Talk organized in a way that is emotionally acceptable to the participants.
As mentioned earlier, hope can also be viewed as a form of quality of life or lifestyle in which some have built their style of living around the concept. Virtually everything they do involves some consideration of hope. Ones personal thinking about self, spouses, extended and close-in family, siblings, employers, friends and acquaintances, neighbors and virtually all others that we have contact with have hope woven into those relationships. Hope that it will remain the same, or that it will change for the better, or somehow be different. Hope is tightly woven into our very essence or being and is the principle upon which we judge and evaluate virtually all our thinking concerning the past, the present, and the future.
From a practical point of view, the concept of hope is difficult to understand, especially in the presence of catastrophic disease. Disease challenges us to live beyond the confines of the disease as we know it or come to understand it. One way of understanding this is to examine the emotional role of medications at the center of disease treatment, most especially cancer treatment. The principal advocates of this are first the practitioner who provides the diagnostic understanding of the disease and prescribes the medication to fight the disease.
And second are the patients who often develop an fixation around the current medication, the clinical research around new medications, and the overall effectiveness of both. What is interesting to note is this authors own experience with his multiple oncology physicians wherein the regular monthly appointments are almost completely focused on the efficacy of the medications that fight the symptoms of the disease itself and the side-effects of the disease fighting medications. Only under a few rare circumstances have we have conversation about feelings, emotional coping strategies, and end-of-life expectations.
Hope is a complex concept that each of us has a multitude of thoughts about. Conceptually, hope may be characterized as a religious phenomenon involving the idea of God and eternal life. On the other hand, but clearly related, hope can be considered a common part of the human ego or the emotional and biological structure of the human person. Finally, while hope is thought to be a universal aspect of all persons, its parts and dimensions certainly have cultural components that differ for all human beings. How one defines hope is both individualistic and group or culturally determined.
Hope does not equal living per se. Some have the idea that if they go through life embracing hope that they are truly living. Yet, hope alone does not and could not define living.If all our ideas, actions, behaviors, thoughts, and the like are based solely on hope, then indeed we are deferring the present reality for the future which is, by definition, hope oriented. While living, meaning the past, present, and future, does contain elements of hope, it is the totality of the hope concept that is problematic as it could keep us from what is happening because we are focused only on hope elements for the future. It is a sort of childhood version of, when I grow up, Im going to be.Hope for the past, present, and future is necessary, but it is the totality of it that does not constitute living in and of itself.
As mentioned, hope feeds the soul with a sense of identity which enables the person to live beyond the current situation that individuals find themselves in. As humans, we are complex individuals who are relatedly close, but not a copy of one another. We are created with the idea of a soul or a sense of self that combines our past, present, and the future. This is best understood as a combination of behaviors, religious beliefs, thoughts, feelings, guidelines, cultural belief systems and the like that can structure how we think and behave. This is most especially the case as we contemplate future thoughts, wishes, desires, and behaviors. How our soul is developed will determine in part how we will behave in the future. And for many, our souls have an exceptionally large religious or spiritual component which serves to help guide us through all our days on Earth.
This is especially the case for those of us with a terminal illness whose end can and is predicted in terms of time-based sequences and levels of disease. The longer the time with the disease and its level provides a statistical determination of the average life span. Hence, the role of hope and its foundation in God becomes even more important to the cancer patient as one prepares for life hereafter. Perhaps the final and most significant statement about hope is the question about God being eternal life. As cancer patients and others face the probability of near death, the idea that God is about eternal life gathers increasing importance and meaning. As human beings facing imminent death, the idea of the hereafter takes on ever-increasing importance. And, for those of us raised with a concept of God as part of our intellect and being, at the very essence of hope then is an ever-strong belief that God is responsible for our hopeful belief in our daily existence and in the afterlife.
Hope is indeed a complex issue for all human beings to deal with. While this complexity applies to all human beings, it is particularly relevant to those whose illness or age is such that it is likely to be more imperative. Hope provides a livable statement about quality of life. As an alternative to the idea of hope as a pathway for disease-fighting, hope can provide a set of statements or directions to be followed for the living of a quality life. While the concrete approach determining a sort of mechanistic attitude is a normal human process, hope can be useful for conceptualizing a much broader approach to living. The dimensions of this are endless and usually involve other people, family, friends and perhaps even volunteering yourself to assisting others in need.
Even though cancer patients must follow a structured path of treatment for disease resolution, that path does not preclude additional elements which have a broader appeal and usefulness for the patient. In fact, an attitude of belief that the future may be pre-determined because of the disease, adding other dimensions like hope to ones living can strengthen ones approach and add richness to their quality living.
To this end then, hope is a gift and becomes the essence of a quality of life issue for us. We surround ourselves with the idea that hope is a gift, and one which has been nurtured by ourselves over time and often nurtured by other people in our lives. We have been taught or otherwise learned that the idea of hope provides one of the principle ways to achieve happiness in life even within the context of catastrophic disease. As we move through our own individual stages of development, hope is a human quality that enables us to create opportunities for positivity and peace of heart.
Follow this link:
Hope And The Patient With Cancer - Curetoday.com
The value of what we have lost in 2020 – Brunswick News
My friend Dan will die today. I am writing this on Friday morning, Oct. 16. Later today, doctors will turn off the machines that are keeping Dan alive. Dans symptoms began two days ago. He is young in his early 30s and this is a shock.
As I have learned of Dans short illness and impending death, I have been especially sad for his young wife. Dan does not have COVID-19 but due to the pandemic, his wife has not been able to visit him as he lay dying.
This is a familiar, tragic story for so many families who have lost loved ones this year. So far, COVID-19 has killed almost 219,000 Americans, and we have heard floods of stories not only of grief but also of the added trauma of separation as loved ones die alone.
We have lost so much this year.
As I am trying to wrap my head around all we have lost, I return to one of the more interesting results from the field of labor economics, a trick used to assign a dollar value to human life.
Certainly, the true value of the lives lost cannot be measured and is known best in the hearts and lives of those who loved them.
But, as impossible as it may be and as dehumanizing as it may seem, the ability to assign an approximate value to human life is an important one in many policy decisions. For example, it can be a factor in determining how we set fines for pollution or other behavior that can be shown to be a risk to life. It can be a factor in settling lawsuits involving loss of life. Or it can be a consideration in evaluating insurance premiums and payouts.
There are a couple of ways to think about the value of a life. One is to consider the productive potential of an individual, which, in theory, is approximately equal to what he or she would earn as a participant in the labor market.
Productive potential, however, is a very narrow way to define ones value.
A more all-encompassing technique is to observe human behavior and to infer from our choices the value we place on our own lives.
Every job has associated with it a risk of injury or death. Other things equal, the higher risk involved in a job, the more an individual in that position is paid. When a market is in equilibrium, workers are indifferent between a higher-paying riskier job and a lower-paying safer job.
This is how we know the dollar value workers place on their own lives.
We can observe labor market behavior to see how much money workers are willing to give up for a specific decrease in their probability of death, and this gives us what is known as the value of statistical life.
There have been many estimates of the value of statistical life, but the EPA currently uses a value of approximately $7.4 million, regardless of the age, income, or other characteristic of the individual.
You can do the math, but we really dont need a dollar sign to know we have lost a lot this year. Praying it ends soon.
Go here to see the original:
The value of what we have lost in 2020 - Brunswick News
Therapy Plus Medication is More Effective Than Medication Alone for Patients With Bipolar Disorder – Pharmacy Times
Therapy Plus Medication is More Effective Than Medication Alone for Patients With Bipolar Disorder
The review, published in JAMA Psychiatry, assessed data from studies that included adult and adolescent patients who were receiving medication for bipolar disorder at the time of the study. Additionally, the patients were randomly assigned to either an active family, individual or group therapy, or "usual care," which meant that the patient was receiving both medication with routine monitoring and support from a psychiatrist.
In total, the studies reviewed by the researchers followed the patients over a period of approximately 1 year; measured rates of recurrence of bipolar disorder, depression, and mania symptoms; and included study attrition or dropout rates.
The results demonstrated that psychoeducation with guided practice of illness management skills in a family or group setting had greater efficacy in reducing recurrences of mania and depressive symptoms than the same strategies in an individual therapy setting. Also, patients who received family-oriented therapies had lower rates of dropout than other patients.
Additionally, cognitive behavioral therapy, family therapy, and interpersonal therapy were more effective at stabilizing symptoms of depression than other types of treatment, according to the study.
The study's lead author, David Miklowitz, PhD, a distinguished professor of psychiatry at the Jane and Terry Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles, explained in a press release that these results show the importance of a support system for those with bipolar disorder.
"Not everyone may agree with me, but I think the family environment is very important in terms of whether somebody stays well," he said in the press release. "There's nothing like having a person who knows how to recognize when you're getting ill and can say, 'you're starting to look depressed or you're starting to get ramped up.' That person can remind their loved one to take their medications or stay on a regular sleep-wake cycle or contact the psychiatrist for a medication evaluation."
Miklowitz noted that this can also be true for patients who may not have close relatives to attend family therapy, as these patients could still receive that type of support through the group therapy environment.
"If you're in group therapy, other members of that group may be able to help you recognize that you're experiencing symptoms," he said in the press release. "People tend to pair off. It's a little bit like the AA model of having a sponsor."
REFERENCETherapy plus medication better than medication alone in bipolar disorder. Los Angeles: University of California Los Angeles Health Sciences; October 14, 2020. https://www.eurekalert.org/pub_releases/2020-10/uoc--tpm101420.php. Accessed October 15, 2020.
See original here:
Therapy Plus Medication is More Effective Than Medication Alone for Patients With Bipolar Disorder - Pharmacy Times
Corporate execs are talking differently on earnings calls to please the machines – CNBC
Would you talk differently if you knew a machine was listening to you and grading you based on what you were saying, or based on whether you were using positive or negative words, or even if the sound of your voice was optimistic or pessimistic?
Apparently, Wall Street executives are talking differently.They are trying to game machine algorithms on earnings calls.
You've heard of George Carlin's "7 words you can't say on TV?"We may now have "words you can't say on an earnings report."
A recent study found that executives on earnings calls are increasingly avoiding using negative words and trying to sound more upbeat, so machine algorithms will score the call as more "positive" than "negative."
Oh man.Anything to fool the algos.
This is a new round in the war between machines and people.Machines can fool people, but people are trying to fool machines, too.
All of this makes sense if you understand the evolution of trying to figure out what is "really" going on with corporate earnings.
First, there were earnings reports, which came out of the creation of the Securities and Exchange Commission in the early 1930s.Then there were earnings calls.Then there were analysts trying to figure out the "body language" of the executives on the calls to determine how they "really" felt about their company prospects.Then came machines listening to executives for keywords that were deemed important and deciding whether the calls sounded "upbeat" or "downbeat" based on the words being used.
Now, there's a new twist:Seems like the executives have figured out that the machines are listening, and that if they (the executives) avoid using certain words that sound "downbeat" or "negative" they can improve the score they will get, and their earnings call will magically sound more positive.
So say Sean Cao, Wei Jiang, Baozhong Yang & Alan L. Zhang, authors of "How to Talk When a Machine Is Listening: Corporate Disclosure in the Age of AI," published on the National Bureau of Economic Research website.
Their main conclusion:"Firms with high expected machine downloads manage textual sentiment and audio emotion in ways catered to machine and AI readers, such as by differentially avoiding words that are perceived as negative by computational algorithms as compared to those by human readers, and by exhibiting speech emotion favored by machine learning software processors."
In other words, humans are using words they think the machines want to hear and that will give them a more positive score.
The authors noted that this effect was particularly notable on companies that had very high interest in their filings.In other words, the more people paying attention, the more likely the execs were to change their behavior.
Of course, we have known for years about the ability of machines to analyze earnings calls, but the authors say "our study is the first to identify and analyze the feedback effect, i.e., how companies adjust the way they talk knowing that machines are listening."
OK, so we are in a giant hall of mirrors. Humans (investors) are trying to figure out what other humans (corporate executives) really feel about their company's prospects by listening to earnings calls that are analyzed by machines, and the humans (corporate executives) are changing their behavior so the machines will tell the other humans (investors) that things are better than they really are, or at least as good as the executives really meant it to sound.
Got that? What could go wrong?
"Humans are taking machines and using them to analyze emotional signals so we can analyze other humans more efficiently," said DataTrek's Nicholas Colas. "But the machines are doing it on a scale humans could never do.There's an endless loop that is being set up, and expect this to get even more refined over time."
Even the study authors are a little worried about where this will ultimately lead us:"Such a feedback effect can lead to unexpected outcomes, such as manipulation and collusion," they said.
Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.
See the article here:
Corporate execs are talking differently on earnings calls to please the machines - CNBC
The Key to Business Growth is as Simple as Looking at Your Employees Actions, New Study will Unveil Best Practices – GlobeNewswire
Boca Raton, FL, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Brandon Hall Group, the preeminent independent human capital management research and advisory firm, launches its 2020 People Data, Analytics and Algorithms Survey to identify the most successful organizations methods, techniques and best practices.
Data science involves collecting, sorting and analyzing large and highly diverse data sets to identify and predict outcomes, activities and actions. People data science leverages data to predict human behaviors, outcomes and actions. It is critical for identifying internal and external influences that impact peoples behavior and reactions, ensuring only the best, most ethical and productive techniques are used.
There is an increasing reliance on people data for decision-making, and the pace and rate of adoption continues to grow, said Brandon Hall Group CEO Mike Cooke. Human resources professionals, having accepted the inevitability of the people data revolution, must now lead their organizations further in this direction.
Part of being more analytically advanced involves how and why data is collected and used, which will be analyzed in this study, said Cliff Stevenson, Principal Workforce Management Analyst at Brandon Hall Group.
Brandon Hall Groups 2020 People Data, Analytics and Algorithms Studyconsists of a survey sent to its global database and scores of qualitative interviews with research participants, HCM Excellence Award winners and its members.
To learn more about this research study or to participate,click here
Those who participate will receive a summary of the results and the ability to connect with Brandon Hall Groups analyst team to gain further understanding of the issues.
-About Brandon Hall Group-
Brandon Hall Group is the worlds only professional-development company that provides data, research, insights and certification to Learning and Talent professionals and organizations. The best companies in the world rely on Brandon Hall Group to help create future-proof employee-development plans for the new era of work and management.
For more than 27 years, BHG empowers, recognizes and certifies excellence in organizations throughout the world, driving the development of more than 10,000,000 employees and executives. Our annual HCM Excellence Awards program was the first to recognize and celebrate organizations for learning and talent, and as the industrys gold standard is known as the Academy Awards of Human Capital Management.
Brandon Hall Groups cloud-based platform delivers evidence-based insights in Learning and Development, Talent Management, Leadership Development, Diversity and Inclusion, Talent Acquisition and HR/Workforce Management for corporate organizations and HCM solution providers.
Excess Sugar(s) May Be Contributing To Mental Disorders And Aggressive Behavior – Anti Aging News
According to research from the University of Colorados Anschutz Medical Campus, sugar intake may play a significant role in mental health disorders and even aggressive behaviour.
Mental health disorders can have damaging effects on all aspects of life, as scientists are investigating the causes of ADHD and bipolar disorder a new catalyst appears to be emerging; according to a recent study fructose and uric acid increases the risk of developing various behavioural conditions.
We present evidence that fructose, by lowering energy in cells, triggers a foraging response similar to what occurs in starvation, says lead author Richard Johnson.
The team explains that foraging responses cause humans to act impulsively, and this survival instinct can also trigger more risk-taking, rapid decision making, and aggressiveness. While genetically this response helped our ancestors to secure food, today, the explosion of additives and sugary foods/beverages to the typical Western diet may be keeping this emergency reflex around needlessly.
While the fructose pathway was meant to aid survival, fructose intake has skyrocketed during the last century and may be in overdrive due to the high amounts of sugar that are in the current Western diet, Johnson adds.
Findings of the report published in the journal Evolution and Human Behavior examining how refined sugars and high fructose corn syrup may be linked to behavioural issues and obesity and Western diets suggest that components of sugar and high fructose corn syrup can trick the body into thinking that it is starving, thereby changing a persons mental state as well.
We do not blame aggressive behavior on sugar, but rather note that it may be one contributor, Johnson explains. The identification of fructose as a risk factor does not negate the importance of genetic, familial, physical, emotional and environmental factors that shape mental health.
Originally posted here:
Excess Sugar(s) May Be Contributing To Mental Disorders And Aggressive Behavior - Anti Aging News